{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:54:20Z","timestamp":1791863660268,"version":"4.3.4"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007871","name":"ECNP","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Applied"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1016\/j.nsa.2023.103929","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T02:31:23Z","timestamp":1702607483000},"page":"103929","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6360-5224","authenticated-orcid":false,"given":"Drummond E-Wen","family":"McCulloch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5812-4220","authenticated-orcid":false,"given":"Juan Pablo","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Dalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eero","family":"Castr\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Erritzoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibe G.","family":"Frokjaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin H.","family":"Preller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8115-0611","authenticated-orcid":false,"given":"Patrick MacDonald","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1508-6866","authenticated-orcid":false,"given":"Gitte Moos","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.nsa.2023.103929_bib1","doi-asserted-by":"crossref","first-page":"S141","DOI":"10.1016\/j.biopsych.2023.02.358","article-title":"Does psilocybin change synaptic vesicular density in the brains of patients with mild cognitive impairment?","volume":"93","author":"Amaev","year":"2023","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.nsa.2023.103929_bib89","doi-asserted-by":"crossref","first-page":"100538","DOI":"10.1016\/j.eclinm.2020.100538","article-title":"Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: an open-label safety and feasibility pilot study","volume":"27","author":"Anderson","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.nsa.2023.103929_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12031-007-0029-0","article-title":"Diffusion tensor imaging (DTI)-based white matter mapping in brain research: a review","volume":"34","author":"Assaf","year":"2008","journal-title":"J Mol Neurosci MN"},{"key":"10.1016\/j.nsa.2023.103929_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.706017","article-title":"Bridging the gap? Altered thalamocortical connectivity in psychotic and psychedelic states","author":"Avram","year":"2021","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.nsa.2023.103929_bib4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/7854_2017_476","article-title":"Hallucinogens in drug discrimination","volume":"36","author":"Baker","year":"2018","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.nsa.2023.103929_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.116980","article-title":"Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention","volume":"218","author":"Barrett","year":"2020","journal-title":"Neuroimage"},{"issue":"4","key":"10.1016\/j.nsa.2023.103929_bib6","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/cpt.2487","article-title":"Acute effects of psilocybin after escitalopram or placebo pretreatment in a randomized, double-blind, placebo-controlled, crossover study in healthy subjects","volume":"111","author":"Becker","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.nsa.2023.103929_bib7","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/jamapsychiatry.2022.2096","article-title":"Percentage of heavy drinking days following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder","volume":"79","author":"Bogenschutz","year":"2022","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.nsa.2023.103929_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neulet.2018.07.038","article-title":"PET imaging of synaptic density: a new tool for investigation of neuropsychiatric diseases","volume":"691","author":"Cai","year":"2019","journal-title":"Neurosci. Lett."},{"issue":"7","key":"10.1016\/j.nsa.2023.103929_bib9","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1021\/acschemneuro.8b00692","article-title":"Chronic, intermittent microdoses of the psychedelic N,N-dimethyltryptamine (DMT) produce positive effects on mood and anxiety in rodents","volume":"10","author":"Cameron","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.nsa.2023.103929_bib10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1021\/acschemneuro.2c00718","article-title":"5-HT2ARs mediate therapeutic behavioral effects of psychedelic tryptamines","volume":"14","author":"Cameron","year":"2023","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.nsa.2023.103929_bib11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neuropharm.2018.03.010","article-title":"The entropic brain - revisited","volume":"142","author":"Carhart-Harris","year":"2018","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.nsa.2023.103929_bib12","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/pr.118.017160","article-title":"REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics","volume":"71","author":"Carhart-Harris","year":"2019","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.nsa.2023.103929_bib90","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of Psilocybin versus Escitalopram for Depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.nsa.2023.103929_bib13","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1073\/pnas.1518377113","article-title":"Neural correlates of the LSD experience revealed by multimodal neuroimaging","volume":"113","author":"Carhart-Harris","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.nsa.2023.103929_bib14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11920-020-1140-y","article-title":"Gender- and sex-based contributors to sex differences in PTSD","volume":"22","author":"Christiansen","year":"2020","journal-title":"Curr. Psychiatr. Rep."},{"issue":"5","key":"10.1016\/j.nsa.2023.103929_bib15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.biopsych.2012.01.027","article-title":"Endogenous opioid release in the human brain reward system induced by acute amphetamine administration","volume":"72","author":"Colasanti","year":"2012","journal-title":"Biol. Psychiatr."},{"issue":"4","key":"10.1016\/j.nsa.2023.103929_bib16","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41591-022-01744-z","article-title":"Increased global integration in the brain after psilocybin therapy for depression","volume":"28","author":"Daws","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.nsa.2023.103929_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2020.11.013","article-title":"Effects of a single dose of psilocybin on behaviour, brain 5-HT2A receptor occupancy and gene expression in the pig","volume":"42","author":"Donovan","year":"2021","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.nsa.2023.103929_bib18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/cercor\/bhab202","article-title":"Psilocybin induces aberrant prediction error processing of tactile mismatch responses\u2014a simultaneous EEG\u2013FMRI study","volume":"32","author":"Duerler","year":"2022","journal-title":"Cerebr. Cortex"},{"issue":"5","key":"10.1016\/j.nsa.2023.103929_bib19","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/s41386-019-0567-5","article-title":"Serotonin release measured in the human brain: a PET study with [11C]CIMBI-36 and d-amphetamine challenge","volume":"45","author":"Erritzoe","year":"2020","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"issue":"22","key":"10.1016\/j.nsa.2023.103929_bib20","first-page":"1704","article-title":"Brain serotonin release is reduced in patients with depression: a [11C]Cimbi-36 positron emission tomography study with a d-amphetamine challenge","volume":"S0006\u20133223","author":"Erritzoe","year":"2022","journal-title":"Biol. Psychiatr."},{"issue":"7","key":"10.1016\/j.nsa.2023.103929_bib21","first-page":"1188","article-title":"Serotonin 2A receptor agonist binding in the human brain with [11C]Cimbi-36: test-retest reproducibility and head-to-head comparison with the antagonist [18F]altanserin","volume":"34","author":"Ettrup","year":"2016","journal-title":"Neuroimage"},{"issue":"4","key":"10.1016\/j.nsa.2023.103929_bib22","doi-asserted-by":"crossref","DOI":"10.1177\/00368504221135469","article-title":"Factors associated with gender and sex differences in anxiety prevalence and comorbidity: a systematic review","volume":"105","author":"Farhane-Medina","year":"2022","journal-title":"Sci. Prog."},{"key":"10.1016\/j.nsa.2023.103929_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2020.116828","article-title":"Idiosynchrony: from shared responses to individual differences during naturalistic neuroimaging","volume":"215","author":"Finn","year":"2020","journal-title":"Neuroimage"},{"key":"10.1016\/j.nsa.2023.103929_bib24","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.neuroimage.2013.08.035","article-title":"Characterization of [11C]Cimbi-36 as an agonist PET radioligand for the 5-HT2A and 5-HT2C receptors in the nonhuman primate brain","volume":"84","author":"Finnema","year":"2014","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.nsa.2023.103929_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0014-2999(95)00234-C","article-title":"A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635","volume":"281","author":"Forster","year":"1995","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.nsa.2023.103929_bib26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.clinph.2008.11.029","article-title":"The mismatch negativity: a review of underlying mechanisms","volume":"120","author":"Garrido","year":"2009","journal-title":"Clin Neurophysiol Off J Int Fed Clin Neurophysiol"},{"key":"10.1016\/j.nsa.2023.103929_bib91","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.nsa.2023.103929_bib95","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0893-133X(98)00089-X","article-title":"Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG","volume":"20","author":"Gouzoulis-Mayfrank","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nsa.2023.103929_bib92","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol. (Oxf.)"},{"issue":"1","key":"10.1016\/j.nsa.2023.103929_bib27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1053\/j.semnuclmed.2016.09.001","article-title":"Imaging in central nervous system drug discovery","volume":"47","author":"Gunn","year":"2017","journal-title":"Semin. Nucl. Med."},{"issue":"11","key":"10.1016\/j.nsa.2023.103929_bib28","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/s41583-019-0221-6","article-title":"The future of rodent models in depression research","volume":"20","author":"Gururajan","year":"2019","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.nsa.2023.103929_bib29","doi-asserted-by":"crossref","DOI":"10.1007\/s00213-013-3006-z","article-title":"Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement","volume":"227","author":"Halberstadt","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.nsa.2023.103929_bib30","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.brainres.2017.06.022","article-title":"Quantitative positron emission tomography in brain research","volume":"1670","author":"Heurling","year":"2017","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.nsa.2023.103929_bib31","doi-asserted-by":"crossref","DOI":"10.2174\/1570159X22666231005090134","article-title":"Sex differences in stress response: classical mechanisms and beyond","volume":"22","author":"Hodes","year":"2023","journal-title":"Curr. Neuropharmacol."},{"issue":"3","key":"10.1016\/j.nsa.2023.103929_bib32","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41386-020-00883-6","article-title":"Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects","volume":"46","author":"Holze","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.nsa.2023.103929_bib33","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/s41386-023-01572-w","article-title":"5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice","volume":"48","author":"Jefferson","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.nsa.2023.103929_bib34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00952990.2016.1170135","article-title":"Long-term follow-up of psilocybin-facilitated smoking cessation","volume":"43","author":"Johnson","year":"2017","journal-title":"Am. J. Drug Alcohol Abuse"},{"issue":"1","key":"10.1016\/j.nsa.2023.103929_bib35","article-title":"Assessing animal affect: an automated and self-initiated judgement bias task based on natural investigative behaviour","volume":"8","author":"Jones","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nsa.2023.103929_bib36","first-page":"1","article-title":"Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats","author":"Kiilerich","year":"2023","journal-title":"Mol. Psychiatr."},{"issue":"20","key":"10.1016\/j.nsa.2023.103929_bib37","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1111\/bph.12710","article-title":"Sex differences in animal models of psychiatric disorders","volume":"171","author":"Kokras","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"19","key":"10.1016\/j.nsa.2023.103929_bib38","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1007\/s00213-015-4026-7","article-title":"Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations","volume":"232","author":"Kometer","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"issue":"11","key":"10.1016\/j.nsa.2023.103929_bib39","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41593-022-01177-4","article-title":"The neural basis of psychedelic action","volume":"25","author":"Kwan","year":"2022","journal-title":"Nat. Neurosci."},{"issue":"4","key":"10.1016\/j.nsa.2023.103929_bib40","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1177\/1099800418776082","article-title":"Biological sex differences in depression: a systematic review","volume":"20","author":"Labaka","year":"2018","journal-title":"Biol. Res. Nurs."},{"key":"10.1016\/j.nsa.2023.103929_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2022.119620","article-title":"Designing drug occupancy studies with PET neuroimaging: sample size, occupancy ranges and analytical methods","volume":"263","author":"Laurell","year":"2022","journal-title":"Neuroimage"},{"issue":"14","key":"10.1016\/j.nsa.2023.103929_bib42","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1016\/j.neuron.2022.05.001","article-title":"Ketamine exerts its sustained antidepressant effects via cell-type-specific regulation of Kcnq2","volume":"110","author":"Lopez","year":"2022","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.nsa.2023.103929_bib43","doi-asserted-by":"crossref","first-page":"3170","DOI":"10.1016\/j.celrep.2018.05.022","article-title":"Psychedelics promote structural and functional neural plasticity","volume":"23","author":"Ly","year":"2018","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.nsa.2023.103929_bib44","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1021\/acsptsci.0c00065","article-title":"Transient stimulation with psychoplastogens is sufficient to initiate neuronal growth","volume":"4","author":"Ly","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"7","key":"10.1016\/j.nsa.2023.103929_bib45","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/s41386-019-0324-9","article-title":"Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels","volume":"44","author":"Madsen","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nsa.2023.103929_bib46","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neurobiolaging.2021.01.016","article-title":"In vivo coupling of dendritic complexity with presynaptic density in primary tauopathies","volume":"101","author":"Mak","year":"2021","journal-title":"Neurobiol. Aging"},{"issue":"5874","key":"10.1016\/j.nsa.2023.103929_bib47","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1150516","article-title":"The antidepressant fluoxetine restores plasticity in the adult visual cortex","volume":"320","author":"Maya Vetencourt","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.nsa.2023.103929_bib48","article-title":"Lasting effects of a single psilocybin dose on resting-state functional connectivity in healthy individuals","author":"McCulloch","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.nsa.2023.103929_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104689","article-title":"Psychedelic resting-state neuroimaging: A review and perspective on balancing replication and novel analyses","volume":"138","author":"McCulloch","year":"2022","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"7","key":"10.1016\/j.nsa.2023.103929_bib49","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/npp.2015.340","article-title":"Blunted endogenous opioid release following an oral amphetamine challenge in pathological gamblers","volume":"41","author":"Mick","year":"2016","journal-title":"Neuropsychopharmacol Off Publ Am Coll Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.nsa.2023.103929_bib50","article-title":"Increasing resolution in stress neurobiology: from single cells to complex group behaviors","volume":"26","author":"Miranda","year":"2023","journal-title":"Stress Amst Neth"},{"issue":"6","key":"10.1016\/j.nsa.2023.103929_bib51","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","article-title":"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB","volume":"26","author":"Moliner","year":"2023","journal-title":"Nat. Neurosci."},{"issue":"12","key":"10.1016\/j.nsa.2023.103929_bib52","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.biopsych.2022.10.021","article-title":"Toward mapping neurobehavioral heterogeneity of psychedelic neurobiology in humans","volume":"93","author":"Moujaes","year":"2023","journal-title":"Biol. Psychiatr."},{"issue":"6","key":"10.1016\/j.nsa.2023.103929_bib53","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/acps.12818","article-title":"Increased thalamic resting-state connectivity as a core driver of LSD-induced hallucinations","volume":"136","author":"M\u00fcller","year":"2017","journal-title":"Acta Psychiatr. Scand."},{"issue":"6","key":"10.1016\/j.nsa.2023.103929_bib54","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1007\/s00213-021-05991-9","article-title":"Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults","volume":"239","author":"Murray","year":"2022","journal-title":"Psychopharmacology (Berl)"},{"issue":"38","key":"10.1016\/j.nsa.2023.103929_bib55","doi-asserted-by":"crossref","first-page":"15171","DOI":"10.1523\/JNEUROSCI.2063-13.2013","article-title":"Broadband cortical desynchronization underlies the human psychedelic state","volume":"33","author":"Muthukumaraswamy","year":"2013","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.nsa.2023.103929_bib56","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"issue":"7966","key":"10.1016\/j.nsa.2023.103929_bib57","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41586-023-06204-3","article-title":"Psychedelics reopen the social reward learning critical period","volume":"618","author":"Nardou","year":"2023","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.nsa.2023.103929_bib58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.biopsych.2006.10.006","article-title":"Long-term plasticity of visually evoked potentials in humans is altered in major depression","volume":"62","author":"Normann","year":"2007","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.nsa.2023.103929_bib59","doi-asserted-by":"crossref","DOI":"10.1177\/1179069518800508","article-title":"Psychoplastogens: a promising class of plasticity-promoting neurotherapeutics","volume":"12","author":"Olson","year":"2018","journal-title":"J. Exp. Neurosci."},{"issue":"4","key":"10.1016\/j.nsa.2023.103929_bib60","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/0269881120981384","article-title":"Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings","volume":"35","author":"Pallavicini","year":"2021","journal-title":"J Psychopharmacol Oxf Engl"},{"issue":"11","key":"10.1016\/j.nsa.2023.103929_bib61","first-page":"1383","article-title":"Animal models of major depression: drawbacks and challenges","volume":"126","author":"Planchez","year":"2019","journal-title":"J Neural Transm Vienna Austria 1996"},{"issue":"3","key":"10.1016\/j.nsa.2023.103929_bib62","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cub.2016.12.030","article-title":"The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation","volume":"27","author":"Preller","year":"2017","journal-title":"Curr. Biol."},{"issue":"2","key":"10.1016\/j.nsa.2023.103929_bib63","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3390\/ijms22020835","article-title":"A single dose of psilocybin increases synaptic density and decreases 5-HT2A receptor density in the pig brain","volume":"22","author":"Raval","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.nsa.2023.103929_bib64","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1038\/s41467-022-29903-3","article-title":"An analysis of neuroscience and psychiatry papers published from 2009 and 2019 outlines opportunities for increasing discovery of sex differences","volume":"13","author":"Rechlin","year":"2022","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.nsa.2023.103929_bib65","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1038\/s41596-020-0382-9","article-title":"A standardized social preference protocol for measuring social deficits in mouse models of autism","volume":"15","author":"Rein","year":"2020","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.nsa.2023.103929_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2022.796129","article-title":"Imaging synaptic density: the next holy grail of neuroscience?","volume":"16","author":"Serrano","year":"2022","journal-title":"Front. Neurosci."},{"issue":"16","key":"10.1016\/j.nsa.2023.103929_bib67","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.neuron.2021.06.008","article-title":"Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo","volume":"109","author":"Shao","year":"2021","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.nsa.2023.103929_bib68","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/s41380-022-01913-z","article-title":"A paradigm shift in translational psychiatry through rodent neuroethology","volume":"28","author":"Shemesh","year":"2023","journal-title":"Mol. Psychiatr."},{"issue":"1","key":"10.1016\/j.nsa.2023.103929_bib69","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/jcbfm.2011.115","article-title":"Within-subject comparison of [11C]-(+)-PHNO and [11C]raclopride sensitivity to acute amphetamine challenge in healthy humans","volume":"32","author":"Shotbolt","year":"2012","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"1","key":"10.1016\/j.nsa.2023.103929_bib70","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/02698811221125354","article-title":"Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression","volume":"37","author":"Shukuroglou","year":"2023","journal-title":"J Psychopharmacol Oxf Engl"},{"key":"10.1016\/j.nsa.2023.103929_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2021.755812","article-title":"PEERS - an open science \u201cplatform for the Exchange of experimental research standards\u201d in biomedicine","volume":"15","author":"Sil","year":"2021","journal-title":"Front. Behav. Neurosci."},{"issue":"7","key":"10.1016\/j.nsa.2023.103929_bib72","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nrn2851","article-title":"Behavioural phenotyping assays for mouse models of autism","volume":"11","author":"Silverman","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nsa.2023.103929_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2022.948729","article-title":"Lasting increases in trait mindfulness after psilocybin correlate positively with the mystical-type experience in healthy individuals","volume":"13","author":"S\u00f8ndergaard","year":"2022","journal-title":"Front. Psychol."},{"issue":"1\u20132","key":"10.1016\/j.nsa.2023.103929_bib74","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0166-4328(96)00081-2","article-title":"Human psychopharmacology of N,N-dimethyltryptamine","volume":"73","author":"Strassman","year":"1995","journal-title":"Behav. Brain Res."},{"issue":"7","key":"10.1016\/j.nsa.2023.103929_bib75","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1111\/j.1460-9568.2005.04007.x","article-title":"Long-term potentiation of human visual evoked responses","volume":"21","author":"Teyler","year":"2005","journal-title":"Eur. J. Neurosci."},{"issue":"4","key":"10.1016\/j.nsa.2023.103929_bib76","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1177\/0271678X20931140","article-title":"In vivo imaging of synaptic SV2A protein density in healthy and striatal-lesioned rats with [11C]UCB-J PET","volume":"41","author":"Thomsen","year":"2021","journal-title":"J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab"},{"issue":"1","key":"10.1016\/j.nsa.2023.103929_bib77","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-51974-4","article-title":"Neural correlates of the DMT experience assessed with multivariate EEG","volume":"9","author":"Timmermann","year":"2019","journal-title":"Sci. Rep."},{"issue":"13","key":"10.1016\/j.nsa.2023.103929_bib78","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2218949120","article-title":"Human brain effects of DMT assessed via EEG-fMRI","volume":"120","author":"Timmermann","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.nsa.2023.103929_bib79","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41398-020-01179-5","article-title":"Effect of 5-HT2A receptor antagonism on levels of D2\/3 receptor occupancy and adverse behavioral side-effects induced by haloperidol: a SPECT imaging study in the rat","volume":"11","author":"Tsartsalis","year":"2021","journal-title":"Transl. Psychiatry"},{"issue":"8","key":"10.1016\/j.nsa.2023.103929_bib80","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/s41380-018-0107-4","article-title":"Blunted endogenous opioid release following an oral dexamphetamine challenge in abstinent alcohol-dependent individuals","volume":"25","author":"Turton","year":"2020","journal-title":"Mol. Psychiatr."},{"issue":"1","key":"10.1016\/j.nsa.2023.103929_bib81","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.neuroimage.2010.06.044","article-title":"Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomy","volume":"54","author":"Tziortzi","year":"2011","journal-title":"Neuroimage"},{"issue":"6633","key":"10.1016\/j.nsa.2023.103929_bib82","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1126\/science.adf0435","article-title":"Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors","volume":"379","author":"Vargas","year":"2023","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.nsa.2023.103929_bib83","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41583-020-0378-z","article-title":"Improving translation of animal models of addiction and relapse by reverse translation","volume":"21","author":"Venniro","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"issue":"6","key":"10.1016\/j.nsa.2023.103929_bib84","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.biopsych.2018.09.032","article-title":"Altered transcranial magnetic stimulation-electroencephalographic markers of inhibition and excitation in the dorsolateral prefrontal cortex in major depressive disorder","volume":"85","author":"Voineskos","year":"2019","journal-title":"Biol. Psychiatr."},{"issue":"5","key":"10.1016\/j.nsa.2023.103929_bib98","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0893-133X(96)00246-1","article-title":"Positron emission tomography and fluorodeoxyglucose studies of metabolic hyperfrontality and psychopathology in the psilocybin model of psychosis","volume":"16","author":"Vollenweider","year":"1997","journal-title":"Neuropsychopharmacology"},{"issue":"17","key":"10.1016\/j.nsa.2023.103929_bib102","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"Vollenweider","year":"1998","journal-title":"Neuroreport"},{"issue":"5","key":"10.1016\/j.nsa.2023.103929_bib86","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0893-133X(98)00108-0","article-title":"5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in Man - a PET study with [11C]raclopride","volume":"20","author":"Vollenweider","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.nsa.2023.103929_bib87","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41380-022-01762-w","article-title":"Introducing a depression-like syndrome for translational neuropsychiatry: a plea for taxonomical validity and improved comparability between humans and mice","volume":"28","author":"von M\u00fccke-Heim","year":"2023","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.nsa.2023.103929_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109504","article-title":"Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders","author":"Wulff","year":"2023","journal-title":"Neuropharmacology"}],"container-title":["Neuroscience Applied"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772408523029113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772408523029113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T03:27:03Z","timestamp":1731382023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772408523029113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":95,"alternative-id":["S2772408523029113"],"URL":"https:\/\/doi.org\/10.1016\/j.nsa.2023.103929","relation":{},"ISSN":["2772-4085"],"issn-type":[{"value":"2772-4085","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Applied","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nsa.2023.103929","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier B.V. on behalf of European College of Neuropsychopharmacology.","name":"copyright","label":"Copyright"}],"article-number":"103929"}}